NCT01799356已完成4 期
Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials
Istanbul Bakirkoy Maternity and Children Diseases Hospital4 个研究点 分布在 1 个国家目标入组 1,303 人开始时间: 2010年6月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 1,303
- 试验地点
- 4
- 主要终点
- Clinically cure
研究概览
简要总结
We aimed to compare efficacy and safety of combination therapy with oral ofloxacin, 400 mg twice daily, plus oral metronidazole, 500 mg twice daily, for 14 days, with moxifloxacin monotherapy, 400 mg once daily, for 14 days
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Investigator)
入排标准
- 年龄范围
- 14 Years 至 45 Years（Child, Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Women diagnosed uncomplicated PID
- •Patients age are between 14 with 45
- •Pelvic tenderness and vaginal discharge
排除标准
- •Urinary Tract Enfections
- •Tubo-ovarian abscess and complicated PID
- •Hıstory of antibiotics treatment
- •Other pelvic pain causes
- •Endometriosis
- •Delivery,abortion and surgery within last months
研究组 & 干预措施
moxifloxacin Group
Active Comparator
Treatment at uPID with moxifloxacin
干预措施: Moxifloxacin (Drug)
Ofloxacin Group
Placebo Comparator
Treatment at uPID with Ofloxacin plus metronidazole
干预措施: Ofloxacin (Drug)
Ofloxacin Group
Placebo Comparator
Treatment at uPID with Ofloxacin plus metronidazole
干预措施: Metronidazole (Drug)
结局指标
主要结局
Clinically cure
时间窗: 21 Days
次要结局
- Microbiological cure(21 Days)
研究者
Osman Aşıcıoğlu
Istanbul Sisli Etfal Training Research Hospital
Istanbul Bakirkoy Maternity and Children Diseases Hospital
研究点 (4)
Loading locations...
相似试验
已完成
3 期
A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory DiseasePelvic Inflammatory DiseaseNCT00453349Bayer460
Unknown
4 期
Efficacy and Safety Trial to Assess Moxifloxacin in Treating Community-Acquired Pneumonia (CAP) With Aspiration FactorsCommunity-Acquired PneumoniaNCT00752947Beijing Hospital186
Unknown
4 期
Efficacy of Three Antibiotic Protocols for Aggressive Periodontitis TreatmentAggressive PeriodontitisNCT02839421Facultad Nacional de Salud Publica36
尚未招募
3 期
Investigating the effect of moxifloxacin in Helicobacter infectioIRCT20240128060832N1Ahvaz University of Medical Sciences246
已完成
3 期
A Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIsInfectious DiseasesNCT00828971Bayer16